These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19106034)

  • 41. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.
    Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J
    Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential.
    Patterson JV; Sandman CA; Ring A; Jin Y; Bunney WE
    Bipolar Disord; 2009 Sep; 11(6):596-609. PubMed ID: 19689502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis.
    Chang WP; Arfken CL; Sangal MP; Boutros NN
    Psychophysiology; 2011 Jul; 48(7):980-92. PubMed ID: 21214588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P50 sensory gating in panic disorder.
    Ghisolfi ES; Heldt E; Zanardo AP; Strimitzer IM; Prokopiuk AS; Becker J; Cordioli AV; Manfro GG; Lara DR
    J Psychiatr Res; 2006 Sep; 40(6):535-40. PubMed ID: 16616936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia.
    Kéri S; Beniczky S; Kelemen O
    Am J Psychiatry; 2010 Apr; 167(4):444-50. PubMed ID: 20048019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Various effects of antipsychotics on P50 sensory gating in Chinese schizophrenia patients: a meta-analysis.
    Su L; Cai Y; Wang L; Shi S
    Psychiatr Danub; 2012 Mar; 24(1):44-50. PubMed ID: 22447085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine.
    Aggernaes B; Glenthoj BY; Ebdrup BH; Rasmussen H; Lublin H; Oranje B
    Int J Neuropsychopharmacol; 2010 Nov; 13(10):1383-95. PubMed ID: 20633319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
    Knott V; Millar A; Fisher D; Albert P
    Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
    Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
    Potter D; Summerfelt A; Gold J; Buchanan RW
    Schizophr Bull; 2006 Oct; 32(4):692-700. PubMed ID: 16469942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired P50 suppression in fear extinction in obsessive-compulsive disorder.
    Nanbu M; Kurayama T; Nakazawa K; Matsuzawa D; Komiya Z; Haraguchi T; Ogura H; Hashimoto T; Yoshida S; Iyo M; Shimizu E
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):317-22. PubMed ID: 20035817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pre-attentive information processing and impulsivity in bipolar disorder.
    Swann AC; Lijffijt M; Lane SD; Steinberg JL; Acas MD; Cox B; Moeller FG
    J Psychiatr Res; 2013 Dec; 47(12):1917-24. PubMed ID: 24054520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
    Micoulaud-Franchi JA; Hetrick WP; Aramaki M; Bolbecker A; Boyer L; Ystad S; Kronland-Martinet R; Richieri R; Faget C; Faugere M; El-Kaim A; Cermolacce M; Lancon C; Vion-Dury J
    Schizophr Res; 2014 Aug; 157(1-3):157-62. PubMed ID: 24893905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased p50 gating but intact prepulse inhibition in borderline personality disorder.
    Grootens KP; van Luijtelaar G; Miller CA; Smits T; Hummelen JW; Buitelaar JK; Verkes RJ
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):348-56. PubMed ID: 18806239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential relationships of impulsivity or antisocial symptoms on P50, N100, or P200 auditory sensory gating in controls and antisocial personality disorder.
    Lijffijt M; Cox B; Acas MD; Lane SD; Moeller FG; Swann AC
    J Psychiatr Res; 2012 Jun; 46(6):743-50. PubMed ID: 22464943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.
    Düring S; Glenthøj BY; Andersen GS; Oranje B
    Neuropsychopharmacology; 2014 Dec; 39(13):3000-8. PubMed ID: 24954063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
    Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
    Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consistency of abnormal sensory gating in first-admission and chronic schizophrenia across quantification methods.
    Schubring D; Popov T; Miller GA; Rockstroh B
    Psychophysiology; 2018 Apr; 55(4):. PubMed ID: 28940501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of midlatency auditory sensory gating at short and long interstimulus intervals.
    Rentzsch J; de Castro AG; Neuhaus A; Jockers-Scherübl MC; Gallinat J
    Neuropsychobiology; 2008; 58(1):11-8. PubMed ID: 18781086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.
    Smucny J; Stevens KE; Tregellas JR
    Pharmacol Biochem Behav; 2014 Mar; 118():22-9. PubMed ID: 24418217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.